Pharmaceuticals

Nanocarriers Market Size Forecast: Revenue and CAGR by 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Nanocarriers Industry Expected To Reach By 2029, Starting From 2025 Levels?

The nanocarriers market has experienced substantial expansion in recent years. Its size is forecast to grow from $9.79 billion in 2024 to $11.61 billion in 2025, at a compound annual growth rate (CAGR) of 18.5%. Historically, this growth was primarily driven by the escalating burden of chronic and oncologic diseases, a greater number of approvals for targeted and personalized therapies, the widespread implementation of national immunization programs and booster initiatives, advancements in biopharmaceutical research and development, and elevated healthcare spending.

The nanocarriers market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $22.67 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 18.2%. Factors driving this growth during the projection period include the expanding aging demographic, the ongoing increase in lifestyle-related ailments, greater utilization of metal and metallic oxide particles, heightened focus on personalized medicine, and increased involvement in clinical trials. Key trends anticipated for the forecast timeframe encompass progress in healthcare technologies, the creation of personalized and adaptive drug delivery mechanisms, the evolution of stimuli-responsive nanocarriers, improvements in 3D printing technologies, and the establishment of adaptable nanocarrier platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28275&type=smp

What Are The Drivers Pushing New Developments In The Nanocarriers Market?

The growing need for personalized medicines is projected to fuel the expansion of the nanocarriers market moving forward. Personalized medicine refers to the approach of tailoring medical treatment to each patient’s specific characteristics, utilizing genetic, biomarker, and molecular information. The focus on personalized medicine is intensifying as it allows doctors to customize cancer treatments based on a patient’s genetic profile, thereby improving effectiveness and minimizing unnecessary side effects. Nanocarriers play a crucial role in personalized medicine by delivering drugs precisely to patient-specific targets, regulating their release, enhancing bioavailability, and enabling customized combination therapies aligned with individual biological profiles. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized therapies for patients with rare diseases, which was a significant increase from just six approvals in 2022. Thus, the increasing demand for personalized medicines is a key driver for the growth of the nanocarriers market.

What Are The Primary Types Of Segments Analyzed In The Nanocarriers Market?

The nanocarriers market covered in this report is segmented as

1) By Type: Polymeric Nanocarriers, Lipid-Based Nanocarriers, Inorganic Nanocarriers, Other Types

2) By Application: Drug Delivery, Diagnostics, Vaccines, Gene Therapy, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Polymeric Nanocarriers: Nanoparticles Of Poly Lactic Acid, Nanoparticles Of Poly Lactic-Co-Glycolic Acid, Nanoparticles Of Chitosan, Nanoparticles Of Gelatin, Nanoparticles Of Polycaprolactone

2) By Lipid-Based Nanocarriers: Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Liposomes, Nanoemulsions, Self-Emulsifying Drug Delivery Systems

3) By Inorganic Nanocarriers: Gold Nanoparticles, Silver Nanoparticles, Silica Nanoparticles, Magnetic Nanoparticles, Quantum Dots

4) By Other Types: Dendrimers, Protein-Based Nanocarriers, Carbon Nanotubes, Nanocrystals, Exosomes

What Long-Term Trends Will Shape The Future Growth Of The Nanocarriers Industry?

Leading companies in the nanocarriers market are prioritizing the development of advanced formulations, including lipid nanoparticle technologies, to enhance targeted drug delivery and improve therapeutic efficacy. Lipid nanoparticle technologies are nanoscale, fat-based carriers engineered to deliver drugs or genetic therapies safely and efficiently to specific cells or tissues. For instance, in July 2023, Cytiva, a US-based biotechnology company, launched the NanoAssemblr commercial formulation system, a single-use, fully automated platform designed to enable end-to-end clinical and commercial manufacturing of lipid nanoparticle (LNP) medicines. This system utilizes Cytiva’s NxGen technology to provide controlled, reproducible mixing for consistent quality throughout all stages from research to large-scale manufacturing under cGMP conditions. The platform reduces cross-contamination risk with its single-use fluid path and supports efficient multi-product manufacturing in one facility. It also features intuitive software compliant with regulatory standards that automates workflows and enables electronic batch records, streamlining production of genomic medicines such as mRNA vaccines, gene therapies, and cancer vaccines.

Who Are The Primary Competitors In The Global Nanocarriers Market?

Major companies operating in the nanocarriers market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, Amgen Inc., Evonik Industries AG, Matinas BioPharma Holdings Inc., Luye Pharma Group Ltd., Ascendia Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Polymun Scientific Immunbiologische Forschung GmbH, ReCode Therapeutics Inc., Celsion Corporation, Starpharma Holdings Limited, EnGeneIC Ltd., Acuitas Therapeutics Inc., Altamira Therapeutics Ltd., Nanexa AB.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nanocarriers-global-market-report

Which Geographies Are Emerging As Strong Markets For The Nanocarriers Industry?

North America was the largest region in the nanocarriers market in 2024. The regions covered in nanocarriers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Nanocarriers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28275&type=smp

Browse Through More Reports Similar to the Global Nanocarriers Market 2025, By The Business Research Company

Microcarrier Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/microcarrier-global-market-report

Nanomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanofibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795